Ratan Capital Management LP Recursion Pharmaceuticals, Inc. Transaction History

Ratan Capital Management LP

  • $354 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$16.14 - $21.86 $566,013 - $766,608
-35,069 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$19.03 - $41.33 $1.43 Million - $3.1 Million
-74,931 Reduced 68.12%
35,069 $807,000
Q2 2021

Aug 16, 2021
BUY
$18.0 - $37.42 $1.98 Million - $4.12 Million
110,000 New
110,000 $4.02 Million

Others Institutions Holding RXRX

# of Institutions
287
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.12B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Ratan Capital Management LP Portfolio

Follow Ratan Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ratan Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Ratan Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email